C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine). C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast. 556
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: